Loncar China BioPharma ETF | |
$ 14.2492 | |
Last Holding update 2023-10-31 | 66 Stocks (0 new) |
Value $4.00 Mil | Turnover 0 % |
Portfolio Report | |
Registrant: ETF Series Solutions
|
Performance
Annualized Return %
Total Annual Return %
Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 14.2492 | ||
Day's Range ($) | 14.2492 - 14.2492 | ||
Day's Volume | 70 | ||
52-Week Range ($) | 13.351 - 22.89 | ||
Beta | - | ||
Volatility | - | ||
14-Day RSI | - | ||
14-Day ATR ($) | 0.134286 | ||
20-Day SMA ($) | - |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | 3.721 | ||
Shares Outstanding (Mil) | - | ||
PE Ratio | - | ||
PE Ratio (10y Range) | 9.4 - 19.4 | ||
PE Ratio (10y Median) | 17.6 | ||
PB Ratio | - | ||
PB Ratio (10y Range) | 1.49 - 3.73 | ||
PB Ratio (10y Median) | 2.88 |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | 0.067 | ||
Dividend Yield % | 0.5 | ||
Dividend Yield % (10y Range) | 0.12 - 22.44 | ||
Dividend Yield % (10y Median) | 0.5 | ||
Next Dividend Payment Date | |||
Dividend Frequency | Annually |
CHNA Loncar China BioPharma ETF Fundamental Charts
Historical TTM Price-to-Earnings for CHNA Loncar China BioPharma ETF
Historical TTM Price-to-Earnings without NRI for CHNA Loncar China BioPharma ETF
Historical Price-to-Book Ratio for CHNA Loncar China BioPharma ETF
Historical Dividend Yields for CHNA Loncar China BioPharma ETF
CHNA Loncar China BioPharma ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:CHNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CHNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Loncar China BioPharma ETF Top Holdings of 2023-08-31
View Full List
Ticker |
---|
HKSE:06660 |
LEGN |
HKSE:02359 |
HKSE:01099 |
BGNE |
HKSE:06826 |
HKSE:02196 |
HKSE:00874 |
HKSE:02607 |
HKSE:02269 |
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HKSE:06660 | AIM Vaccine Co Ltd | 29,400 | 185.210 | 0% | 4.490 | 0% | 0.000 | +23.06% | -0.76% | 9434.177 | Biotechnology | |
LEGN | Legend Biotech Corp | 1,841 | 127.690 | 0% | 3.090 | 0% | 0.000 | -27.84% | -32.96% | 7387.203 | Biotechnology | |
HKSE:02359 | Wuxi AppTec Co Ltd | 10,257 | 112.360 | 0% | 2.720 | 0% | 0.000 | +63.06% | -26.51% | 172965.099 | Medical Diagnostics & Research | |
HKSE:01099 | Sinopharm Group Co Ltd | 36,700 | 106.470 | 0% | 2.580 | 0% | 0.000 | +3.60% | +5.81% | 64597.582 | Medical Distribution | |
BGNE | BeiGene Ltd | 507 | 105.230 | 0% | 2.550 | 0% | 0.000 | +12.43% | +13.92% | 23050.554 | Biotechnology | |
HKSE:06826 | Shanghai Haohai Biological Technology Co Ltd | 25,480 | 102.580 | 0% | 2.490 | 0% | 0.010 | +10.47% | +16.65% | 15960.850 | Biotechnology | |
HKSE:02196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 40,500 | 95.340 | 0% | 2.310 | 0% | 0.000 | +16.06% | -7.77% | 70765.159 | Drug Manufacturers | |
HKSE:00874 | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd | 31,000 | 87.170 | 0% | 2.110 | 0% | 0.000 | -2.56% | -8.01% | 48790.680 | Medical Distribution | |
HKSE:02607 | Shanghai Pharmaceuticals Holding Co Ltd | 51,700 | 85.050 | 0% | 2.060 | 0% | 0.000 | +11.64% | +17.77% | 72782.377 | Medical Distribution | |
HKSE:02269 | WuXi Biologics (Cayman) Inc | 15,000 | 84.450 | 0% | 2.050 | 0% | 0.000 | +48.06% | -43.18% | 69032.996 | Biotechnology |
Loncar China BioPharma ETF's Historical Top Holdings Breakdowns
Loncar China BioPharma ETF's Top Stock Picks
View Full List
Ticker |
---|
HKSE:01093 |
HKSE:01177 |
HKSE:02269 |
HKSE:03347 |
HKSE:02196 |
HKSE:06606 |
BGNE |
HKSE:02359 |
HKSE:09995 |
HKSE:01099 |
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
HKSE:01093 | CSPC Pharmaceutical Group Ltd | 2023-05-31 | Reduce | -0.22% | 6.82 (HK$7.81) 8.76 | HK$5.35 | -31.50% | Reduce -9.77% | 110,880 | -12,000 | |
HKSE:01177 | Sino Biopharmaceutical Ltd | 2023-05-31 | Reduce | -0.18% | 3.73 (HK$4.24) 4.62 | HK$3.40 | -19.81% | Reduce -8.39% | 218,500 | -20,000 | |
HKSE:02269 | WuXi Biologics (Cayman) Inc | 2023-05-31 | Reduce | -0.18% | 40.05 (HK$48.25) 57.25 | HK$16.82 | -65.14% | Reduce -9.09% | 15,000 | -1,500 | |
HKSE:03347 | Hangzhou Tigermed Consulting Co Ltd | 2023-05-31 | Reduce | -0.18% | 57.45 (HK$73.03) 88.2 | HK$37.75 | -48.31% | Reduce -8.49% | 9,700 | -900 | |
HKSE:02196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2023-05-31 | Reduce | -0.18% | 21.15 (HK$22.35) 23.85 | HK$15.32 | -31.45% | Reduce -7.95% | 40,500 | -3,500 | |
HKSE:06606 | New Horizon Health Ltd | 2023-05-31 | Reduce | -0.18% | 25.6 (HK$29.46) 34.55 | HK$14.14 | -52.00% | Reduce -10.42% | 21,500 | -2,500 | |
BGNE | BeiGene Ltd | 2023-05-31 | Reduce | -0.18% | 212 ($238.04) 266.78 | $205.98 | -13.47% | Reduce -8.32% | 507 | -46 | |
HKSE:02359 | Wuxi AppTec Co Ltd | 2023-05-31 | Reduce | -0.17% | 64.5 (HK$76.53) 89.9 | HK$56.50 | -26.17% | Reduce -8.07% | 10,257 | -900 | |
HKSE:09995 | RemeGen Co Ltd | 2023-05-31 | Reduce | -0.17% | 33.85 (HK$44.91) 54.5 | HK$19.14 | -57.38% | Reduce -12% | 11,000 | -1,500 | |
HKSE:01099 | Sinopharm Group Co Ltd | 2023-05-31 | Reduce | -0.17% | 21.6 (HK$25.23) 28.25 | HK$20.70 | -17.95% | Reduce -8.93% | 36,700 | -3,600 |
Loncar China BioPharma ETF Total Holding History ($B)
Loncar China BioPharma ETF's Asset Allocation
Loncar China BioPharma ETF Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Loncar China BioPharma ETF's Hypothetical Growth since 2023-08-31
Loncar China BioPharma ETF's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Loncar China BioPharma ETF's Holdings Heat Map
Size field:
Loncar China BioPharma ETF's Holdings Bubble Chart
Loncar China BioPharma ETF News
- 1